Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Aprea Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 24 | 28 | +4 |
| Shares | 1.63M | 2.08M | +458.6K (+28.2%) |
| Value | $10.8M | $8.48M | −$2.29M (−21.3%) |
New holders (7)
Institutions that held Aprea Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 137,197 | $558.4K | 0.23% |
| Stonepine Capital Management, LLC | 137,174 | $558.3K | 0.51% |
| Exome Asset Management LLC | 137,174 | $558.3K | 0.50% |
| Dimensional Fund Advisors LP | 11,071 | $45.1K | 0.00% |
| Susquehanna International Group, LLP | 10,119 | $41.2K | 0.00% |
| JPMorgan Chase & Co | 12 | $49 | 0.00% |
| Aviso Financial Inc. | 10 | $41 | 0.00% |
Sold out (3)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| FMR LLC | 161 | $1.08K |
| Princeton Global Asset Management LLC | 100 | $669 |
| Old Point Trust & Financial Services N A | 50 | $335 |